Paxlovid Cuts Odds for Hospitalization After Omicron Infection by 45%
MONDAY, June 27, 2022 (HealthDay News) — Paxlovid appears to living up to its reputation as the Tamiflu treatment for COVID-19, maintaining its effectiveness even against emerging variants, a new study shows. The antiviral COVID pill reduced the risk of hospitalization by 45% when administered to people infected by theContinue Reading